4-chloro-m-cresol cannot detect malignant hyperthermia equivocal cells in an alternative minimally invasive diagnostic test of malignant hyperthermia susceptibility.
Malignant hyperthermia (MH) is an inherited skeletal muscle disorder triggered by commonly used anesthetics. Mutated ryanodine receptors have been identified as molecular targets. The sensitivity of myotubes from individuals classified by the in vitro contracture test as MH susceptible (MHS), normal (MHN), and equivocal (MHEH) was assessed for the Ca2+-releasing activity of 4-chloro-m-cresol (4-CmC) and caffeine. In this study, we sought to determine whether 4-CmC can differentiate the MH status of an individual on the basis of the release of intracellular Ca2+, particularly in regard to MHEH diagnosis. Intracellular Ca2+ concentration was determined photometrically with Fura2. Regions of the ryanodine receptor 1 harboring most of the described MH mutations were sequenced from MHS and MHEH cells. One MH mutation (Gly2434Arg) was found in one MHS individual. Results of the caffeine-induced Ca2+ release in MHS and MHN cells correlated well with the in vitro contracture test results. MHS cells showed a higher sensitivity against caffeine and, to a lesser extent, against 4-CmC. Cells of MHEH individuals showed low sensitivities against both caffeine and 4-CmC, comparable to those of the MHN group. Therefore, with myotubes, caffeine was able to discriminate between MHS and MHN cells, but both caffeine and 4-CmC failed to detect MHEH cells.
Departments of *Anesthesiology and Intensive Care Medicine (B) and †Surgery, Medical University Vienna, Vienna, Austria.
Lukas G
LG
Weigl
Carmen
C
Ludwig-Papst
Hans G
HG
Kress
D002110:Caffeine / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism; D002138:Calibration; D002478:Cells, Cultured; D000697:Central Nervous System Stimulants / Q000494:pharmacology; D003408:Cresols; D004252:DNA Mutational Analysis; D018076:DNA, Complementary / Q000235:genetics; D005456:Fluorescent Dyes; D016257:Fura-2; D006801:Humans; D008305:Malignant Hyperthermia / Q000175:diagnosis* / Q000235:genetics / Q000473:pathology*; D008870:Microtubules / Q000187:drug effects / Q000378:metabolism; D009119:Muscle Contraction / Q000187:drug effects; D009131:Muscle, Smooth, Vascular / Q000166:cytology* / Q000187:drug effects*; D012333:RNA, Messenger / Q000235:genetics; D019837:Ryanodine Receptor Calcium Release Channel / Q000187:drug effects
D000697:Central Nervous System Stimulants; D003408:Cresols; D018076:DNA, Complementary; D005456:Fluorescent Dyes; D012333:RNA, Messenger; D019837:Ryanodine Receptor Calcium Release Channel; C006984:chlorocresol; D002110:Caffeine; D002118:Calcium; D016257:Fura-2